Antacid
- Product NDC
- 68210-4171
- 11-digit product format
- 682104171
- Labeler code
- 68210
- Product ID
- 68210-4171_eecb8f0a-99a0-28e1-e053-2995a90a25bc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Magnesium Oxide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Spirit Pharmaceuticals LLC
- Application
- part331
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2021-11-16
- Marketing end
- 0000-00-00
- Substance
- MAGNESIUM OXIDE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68210-4171-3 | Antacid | 30 in 1 POUCH | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68210-4171 | ANTACID (MAGNESIUM OXIDE) TABLET [SPIRIT PHARMACEUTICALS LLC] | 5 | Legacy NDC, 1 package rows | 20241211_1ad609ca-8108-4144-935d-0673013dbc1f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68210-4171-3 | 68210417103 | 30 TABLET in 1 POUCH (68210-4171-3) | 30 tablet | 2021-11-16 | 0000-00-00 | No | No | Current |